Search research articles
Contact Us
Filters
Showing results (221-230 of 437) with videos related to
Page
of 44
Sort By:
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research
|
April 14, 2025
Identifying the Influential Dynamic Inputs in Cost-Effectiveness Analyses
Melanie D Whittington, Joshua T Cohen, Peter J Neumann, et al.
Radiology
|
June 13, 2003
Cost-effectiveness of PET in the diagnosis of Alzheimer disease
Pamela M McMahon, Sally S Araki, Eileen A Sandberg, et al.
Health Affairs (Project Hope)
|
November 5, 2019
Little Consistency In Evidence Cited By Commercial Plans For Specialty Drug Coverage
James D Chambers, Ari D Panzer, Elle F Pope, et al.
Headache
|
August 20, 2005
Cost-effectiveness of topiramate in migraine prevention: results from a pharmacoeconomic model of topiramate treatment
Jeffrey S Brown, George Papadopoulos, Peter J Neumann, et al.
The American Journal of Managed Care
|
April 12, 2008
A strategic plan for integrating cost-effectiveness analysis into the US healthcare system
Peter J Neumann, Jennifer A Palmer, Norman Daniels, et al.
Health Affairs Scholar
|
February 25, 2026
FDA approvals of specialty drugs, 2000-2024
Sophie E Knox, Claire H Brennan, Daniel E Enright, et al.
Health Affairs Scholar
|
July 28, 2025
What drug characteristics explain the wide range of manufacturer rebates?
Molly T Beinfeld, Fariel LaMountain, Glenn Phillips, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research
|
August 2, 2024
The Health Benefits, Costs, and Cost-Effectiveness of Ultraorphan Drugs
Katherine A Clifford, A Alex Levine, Daniel E Enright, et al.
The Korean Journal of Pain
|
July 15, 2016
Presentation of Neurolytic Effect of 10% Lidocaine after Perineural Ultrasound Guided Injection of a Canine Sciatic Nerve: A Pilot Study
David D Kim, Asma Asif, Sandeep Kataria
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research
|
October 29, 2021
Do Centers for Medicare and Medicaid Services Quality Measures Reflect Cost-Effectiveness Evidence?
Timothy J van Dover, David D Kim
Page
of 44
Search research articles
Search
Showing results (221-230 of 437) with videos related to
Sort By:
Page
of 44
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research
|
April 14, 2025
Identifying the Influential Dynamic Inputs in Cost-Effectiveness Analyses
Melanie D Whittington, Joshua T Cohen, Peter J Neumann, et al.
Radiology
|
June 13, 2003
Cost-effectiveness of PET in the diagnosis of Alzheimer disease
Pamela M McMahon, Sally S Araki, Eileen A Sandberg, et al.
Health Affairs (Project Hope)
|
November 5, 2019
Little Consistency In Evidence Cited By Commercial Plans For Specialty Drug Coverage
James D Chambers, Ari D Panzer, Elle F Pope, et al.
Headache
|
August 20, 2005
Cost-effectiveness of topiramate in migraine prevention: results from a pharmacoeconomic model of topiramate treatment
Jeffrey S Brown, George Papadopoulos, Peter J Neumann, et al.
The American Journal of Managed Care
|
April 12, 2008
A strategic plan for integrating cost-effectiveness analysis into the US healthcare system
Peter J Neumann, Jennifer A Palmer, Norman Daniels, et al.
Health Affairs Scholar
|
February 25, 2026
FDA approvals of specialty drugs, 2000-2024
Sophie E Knox, Claire H Brennan, Daniel E Enright, et al.
Health Affairs Scholar
|
July 28, 2025
What drug characteristics explain the wide range of manufacturer rebates?
Molly T Beinfeld, Fariel LaMountain, Glenn Phillips, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research
|
August 2, 2024
The Health Benefits, Costs, and Cost-Effectiveness of Ultraorphan Drugs
Katherine A Clifford, A Alex Levine, Daniel E Enright, et al.
The Korean Journal of Pain
|
July 15, 2016
Presentation of Neurolytic Effect of 10% Lidocaine after Perineural Ultrasound Guided Injection of a Canine Sciatic Nerve: A Pilot Study
David D Kim, Asma Asif, Sandeep Kataria
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research
|
October 29, 2021
Do Centers for Medicare and Medicaid Services Quality Measures Reflect Cost-Effectiveness Evidence?
Timothy J van Dover, David D Kim
Page
of 44